SONIC HEALTHCARE LIMITED (SHL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

SHL

SHL - SONIC HEALTHCARE LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 3.24
Index: ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

Sonic Healthcare is one of the world's largest medical diagnostics companies, providing laboratory and imaging services to medical practitioners, hospitals, community health services, and their collective patients. It was first listed in 1987.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$23.19

25 Nov
2025

-0.350

OPEN

$23.40

-1.49%

HIGH

$23.59

1,837,436

LOW

$23.10

TARGET
$27.166 17.1% upside
Franking for last dividend paid out: 35%
OTHER COMPANIES IN THE SAME SECTOR
ACL . AHX . ALC . BMT . DOC . EBO . HLS . IDX . M7T . MDR . MPL . MVF . NHF . RHC .
FNARENA'S MARKET CONSENSUS FORECASTS
SHL: 1
Title FY24
Actual		 FY25
Actual		 FY26
Forecast		 FY27
Forecast
EPS (cps) xxx 107.0 123.4 xxx
DPS (cps) xxx 107.0 105.9 xxx
EPS Growth xxx - 0.4% 15.3% xxx
DPS Growth xxx 0.9% - 1.0% xxx
PE Ratio xxx N/A 19.0 xxx
Dividend Yield xxx N/A 4.5% xxx
Div Pay Ratio(%) xxx 100.0% 85.8% xxx

Dividend yield today if purchased 3 years ago: 3.34%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 4.58

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 04/09 - (franking ex-di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx107.0
DPS All xxxxxxxxxxxxxxx107.0
Sales/Revenue xxxxxxxxxxxxxxx9,489.5 M
Book Value Per Share xxxxxxxxxxxxxxx1,733.3
Net Operating Cash Flow xxxxxxxxxxxxxxx1,296.8 M
Net Profit Margin xxxxxxxxxxxxxxx5.41 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx6.32 %
Return on Invested Capital xxxxxxxxxxxxxxx4.14 %
Return on Assets xxxxxxxxxxxxxxx3.21 %
Return on Equity xxxxxxxxxxxxxxx6.32 %
Return on Total Capital xxxxxxxxxxxxxxx5.95 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx446.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx461 M
Long Term Debt xxxxxxxxxxxxxxx4,710 M
Total Debt xxxxxxxxxxxxxxx5,171 M
Goodwill - Gross xxxxxxxxxxxxxxx9,315 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx674 M
Price To Book Value xxxxxxxxxxxxxxx1.55

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx462.7 M
Capex % of Sales xxxxxxxxxxxxxxx4.88 %
Cost of Goods Sold xxxxxxxxxxxxxxx7,072 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx1,637 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx231 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.4

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

21/11/2025

3

Equal-weight

$24.50

5.65%

Morgan Stanley increases EPS estimates for Sonic Healthcare by 2% following updated FY26 guidance. EBITDA guidance was reiterated at $1.87-95bn, with the first half expected to represent around 45-46% of the full year.

The broker expects acquisitions and FX movements will provide positive contributions to FY26, with its forecasts implying constant currency earnings growth of around 5%.

Target is raised to $24.50 from $23.80. Equal-weight rating. Industry View: In-Line.

FORECAST
Morgan Stanley forecasts a full year FY26 dividend of 111.00 cents and EPS of 120.00 cents.
Morgan Stanley forecasts a full year FY27 dividend of 113.00 cents and EPS of 128.00 cents.

Bell Potter

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

24/11/2025

3

Neutral

$26.27

13.28%

Jarden assesses Sonic Healthcare's AGM update showed a solid start to FY26, with revenue up 17% versus the prior year and organic growth of 5% constant currency, ahead of the broker's 15% 1H26 expectation.

Despite this, earnings (EBITDA) guidance of $1.87-1.95bn constant currency was unchanged. This outcome implies to the analysts ongoing margin pressure from funding cuts and the dilutive acquisitions of Labor Dr. Wisplinghoff and Health & Wellbeing England.

Jarden revises its EPS forecasts by 3.4%, -4.0% and -4.6%, respectively, across FY26-28, lowers its target by circa -6% to $26.27, and retains a Neutral rating.

FORECAST
Jarden forecasts a full year FY26 dividend of 106.30 cents and EPS of 125.70 cents.
Jarden forecasts a full year FY27 dividend of 108.30 cents and EPS of 143.20 cents.
Access Extra Coverage Research History >

SHL STOCK CHART

FNArena News on SHL

1
Australian Broker Call *Extra* Edition – Nov 24, 2025

Nov 24 2025 - Daily Market Reports
2
Rudi’s View: New Trends & Recurring Anxieties

Nov 12 2025 - Rudi's View
3
Rudi’s View: Amcor, Charter Hall, Challenger, Goodman, Woolworths & More

Nov 06 2025 - Rudi's View
4
Rudi’s View: Eagers Automotive, Catapult, Fineos, Pro Medicus, Woolworths & More

Oct 30 2025 - Rudi's View
5
Rudi’s View: ALS, Bega, Coles, Elders, Light & Wonder, Lovisa, Telix & More

Oct 23 2025 - Rudi's View

Latest Healthcare services News

1
Better Times Ahead For Sonic Healthcare?

Jun 20 2025 - Australia
2
The Significance Of Cosmetique’s ASX Listing

Feb 26 2025 - Small Caps
3
Building The No 3 Diagnostic Imaging Player

Jun 19 2024 - Small Caps
4
Capitol Health’s Higher Margin Outlook

Mar 13 2024 - Small Caps
5
Treasure Chest: Ramsay Health Care

Oct 26 2023 - Treasure Chest
6
Timing Seems Right For Alcidion Group

Jun 21 2023 - Small Caps
7
No Enthusiasm To Combine ACL & Healius

Mar 21 2023 - Australia
8
Dr Boreham’s Crucible: Alcidion

Dec 13 2022 - Small Caps
9
No Straight Covid-Relief For Ramsay Health Care

Nov 15 2022 - Australia
10
Dr Boreham’s Crucible: Mach7 Technologies

Nov 14 2022 - Small Caps